fr 41565 has been researched along with 6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine in 1 studies
Studies (fr 41565) | Trials (fr 41565) | Recent Studies (post-2010) (fr 41565) | Studies (6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine) | Trials (6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine) | Recent Studies (post-2010) (6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine) |
---|---|---|---|---|---|
57 | 0 | 8 | 17 | 1 | 4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Endo, Y; Sato, T; Shikama, Y; Shimauchi, H; Takada, H | 1 |
1 other study(ies) available for fr 41565 and 6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine
Article | Year |
---|---|
Analgesic effects of chemically synthesized NOD1 and NOD2 agonists in mice.
Topics: Acetic Acid; Acetylmuramyl-Alanyl-Isoglutamine; Analgesics; Animals; Diaminopimelic Acid; Drug Antagonism; Female; Interleukin-1; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Naloxone; Narcotic Antagonists; Nod1 Signaling Adaptor Protein; Nod2 Signaling Adaptor Protein; Oligopeptides; Pain; Pain Measurement; Time Factors; Tumor Necrosis Factor-alpha | 2011 |